Microinfusion of medications into the skin (MMP®) using tattoo devices is a promising transdermal drug delivery technique that creates microchannels for localized drug deposition, minimizing systemic absorption and adverse effects. A review of 14 studies from 2013 to 2025 highlights its effectiveness, particularly in treating alopecia, with 8 studies showing significant improvements in androgenetic alopecia, alopecia areata, and frontal fibrosing alopecia. Additionally, MMP® has shown benefits in treating scars, striae, basal cell carcinoma, and psoriasis vulgaris. The technique's ability to deliver medications uniformly at targeted skin depths, along with its minimal invasiveness and favorable safety profile, positions it as a valuable alternative to traditional methods, with the microneedling effect potentially offering therapeutic benefits on its own.
July 2025 in “Skin Appendage Disorders” Dutasteride microinfusion and microneedling both effectively treat male hair loss.
June 2024 in “Archives of dermatological research” Both treatments work, but Minoxidil 0.5% MMP® is better for certain scalp areas and less advanced hair loss.
June 2023 in “Brazilian Journal of Case Reports” Botulinum Toxin Type A delivered through the skin may be a promising treatment for Frontal Fibrosing Alopecia.
May 2023 in “JAAD international” Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.
March 2023 in “Anais Brasileiros De Dermatologia” Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.
January 2023 in “Skin appendage disorders” Scalp microinfusion is a new method for treating hair loss that shows promise but needs more research for standardization.
19 citations
,
March 2019 in “International Journal of Dermatology” The tattoo machine method safely delivers an average of 1,175 µg/cm² of medication into the skin.
5 citations
,
January 2016 in “Surgical and Cosmetic Dermatology”
45 citations
,
August 2019 in “Dermatologic Therapy” Hair loss treatments work better with lifestyle changes.
October 2025 in “Bioactive Materials” Combining traditional Chinese medicine with microneedles shows promise for effectively treating skin diseases with fewer side effects.
42 citations
,
January 2021 in “Journal of Clinical Medicine” Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.
September 2024 in “Journal of Skin and Stem Cell” MMP® with minoxidil may improve hair growth in chronic telogen effluvium.
19 citations
,
March 2019 in “International Journal of Dermatology” The tattoo machine method safely delivers an average of 1,175 µg/cm² of medication into the skin.